NanoVibronix (NAOV) Competitors $1.17 -0.12 (-9.30%) As of 03:02 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NAOV vs. BTCY, ICU, PAVM, CODX, ALUR, PSTV, MHUA, SSKN, POAI, and NUROShould you be buying NanoVibronix stock or one of its competitors? The main competitors of NanoVibronix include Biotricity (BTCY), SeaStar Medical (ICU), PAVmed (PAVM), Co-Diagnostics (CODX), Allurion Technologies (ALUR), Plus Therapeutics (PSTV), Meihua International Medical Technologies (MHUA), STRATA Skin Sciences (SSKN), Predictive Oncology (POAI), and NeuroMetrix (NURO). These companies are all part of the "medical equipment" industry. NanoVibronix vs. Biotricity SeaStar Medical PAVmed Co-Diagnostics Allurion Technologies Plus Therapeutics Meihua International Medical Technologies STRATA Skin Sciences Predictive Oncology NeuroMetrix Biotricity (NASDAQ:BTCY) and NanoVibronix (NASDAQ:NAOV) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, valuation, earnings, institutional ownership, risk, analyst recommendations, profitability and community ranking. Does the media refer more to BTCY or NAOV? In the previous week, NanoVibronix had 3 more articles in the media than Biotricity. MarketBeat recorded 3 mentions for NanoVibronix and 0 mentions for Biotricity. NanoVibronix's average media sentiment score of 0.90 beat Biotricity's score of 0.00 indicating that NanoVibronix is being referred to more favorably in the news media. Company Overall Sentiment Biotricity Neutral NanoVibronix Positive Do insiders & institutionals have more ownership in BTCY or NAOV? 3.9% of Biotricity shares are owned by institutional investors. Comparatively, 16.4% of NanoVibronix shares are owned by institutional investors. 10.1% of Biotricity shares are owned by insiders. Comparatively, 7.0% of NanoVibronix shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Do analysts recommend BTCY or NAOV? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biotricity 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00NanoVibronix 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community believe in BTCY or NAOV? NanoVibronix received 71 more outperform votes than Biotricity when rated by MarketBeat users. Likewise, 57.26% of users gave NanoVibronix an outperform vote while only 0.00% of users gave Biotricity an outperform vote. CompanyUnderperformOutperformBiotricityOutperform VotesNo VotesUnderperform Votes2100.00% NanoVibronixOutperform Votes7157.26% Underperform Votes5342.74% Is BTCY or NAOV more profitable? Biotricity has a net margin of -80.42% compared to NanoVibronix's net margin of -93.80%. Biotricity's return on equity of 0.00% beat NanoVibronix's return on equity.Company Net Margins Return on Equity Return on Assets Biotricity-80.42% N/A -188.47% NanoVibronix -93.80%-101.17%-53.03% Which has preferable earnings & valuation, BTCY or NAOV? NanoVibronix has lower revenue, but higher earnings than Biotricity. Biotricity is trading at a lower price-to-earnings ratio than NanoVibronix, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiotricity$12.06M1.04-$14.09M-$1.08-0.47NanoVibronix$2.56M0.39-$3.71M-$13.53-0.09 Which has more volatility and risk, BTCY or NAOV? Biotricity has a beta of 1.22, suggesting that its stock price is 22% more volatile than the S&P 500. Comparatively, NanoVibronix has a beta of 2.03, suggesting that its stock price is 103% more volatile than the S&P 500. SummaryBiotricity and NanoVibronix tied by winning 8 of the 16 factors compared between the two stocks. Get NanoVibronix News Delivered to You Automatically Sign up to receive the latest news and ratings for NAOV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAOV vs. The Competition Export to ExcelMetricNanoVibronixSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$987,000.00$9.62B$5.40B$8.53BDividend YieldN/A1.61%5.22%4.11%P/E Ratio-0.9721.1726.7419.97Price / Sales0.3965.49394.93122.22Price / CashN/A19.6738.2534.62Price / Book0.625.156.874.59Net Income-$3.71M$284.66M$3.23B$248.18M7 Day Performance-68.59%0.36%5.01%2.15%1 Month Performance-80.33%6.24%12.82%16.14%1 Year Performance-85.45%-20.02%17.63%8.06% NanoVibronix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAOVNanoVibronix0.4651 of 5 stars$1.17-9.3%N/A-83.7%$971,000.00$2.56M-0.9620Earnings ReportGap DownBTCYBiotricityN/A$0.51+0.8%N/A-53.9%$12.80M$12.06M-0.4840Gap UpICUSeaStar Medical0.9319 of 5 stars$1.27+2.0%N/A-87.4%$12.45M$135,000.00-0.112Earnings ReportPAVMPAVmed4.1253 of 5 stars$0.71+3.6%$19.50+2,661.3%-65.6%$12.07M$3.00M-0.1690CODXCo-Diagnostics4.2636 of 5 stars$0.34+0.5%$5.50+1,510.1%-75.0%$11.47M$3.92M-0.25100Gap UpALURAllurion Technologies3.5082 of 5 stars$2.38flat$22.83+859.4%-92.4%$11.41M$32.11M-0.20501News CoverageEarnings ReportAnalyst RevisionGap DownPSTVPlus Therapeutics1.3969 of 5 stars$0.64-2.7%$11.50+1,691.6%-85.4%$10.91M$4.91M-0.2520Gap UpMHUAMeihua International Medical TechnologiesN/A$0.43+38.7%N/A-49.8%$10.78M$96.91M0.00620Positive NewsGap DownSSKNSTRATA Skin Sciences2.4992 of 5 stars$2.54+3.3%$6.00+136.2%-37.5%$10.59M$33.56M-0.95120Earnings ReportPOAIPredictive Oncology2.0622 of 5 stars$1.12+0.9%$3.00+167.9%-34.9%$10.00M$1.62M-0.3730News CoverageEarnings ReportGap UpNURONeuroMetrix0.1338 of 5 stars$4.55+4.4%N/A+14.3%$9.37M$3.03M-0.9920High Trading Volume Related Companies and Tools Related Companies Biotricity Competitors SeaStar Medical Competitors PAVmed Competitors Co-Diagnostics Competitors Allurion Technologies Competitors Plus Therapeutics Competitors Meihua International Medical Technologies Competitors STRATA Skin Sciences Competitors Predictive Oncology Competitors NeuroMetrix Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NAOV) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NanoVibronix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NanoVibronix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NAOV Stock Free NAOV Stock Alerts